Details for New Drug Application (NDA): 201699
✉ Email this page to a colleague
The generic ingredient in DIFICID is fidaxomicin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fidaxomicin profile page.
Summary for 201699
Tradename: | DIFICID |
Applicant: | Cubist Pharms Llc |
Ingredient: | fidaxomicin |
Patents: | 5 |
Suppliers and Packaging for NDA: 201699
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIFICID | fidaxomicin | TABLET;ORAL | 201699 | NDA | Merck Sharp & Dohme LLC | 52015-080 | 52015-080-01 | 1 BOTTLE in 1 CARTON (52015-080-01) / 20 TABLET, FILM COATED in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | May 27, 2011 | TE: | RLD: | Yes | |||||
Regulatory Exclusivity Expiration: | Jan 24, 2027 | ||||||||
Regulatory Exclusivity Use: | PEDIATRIC PATIENTS AGED 6 MONTHS AND OLDER FOR THE TREATMENT OF C. DIFFICILE-ASSOCIATED DIARRHEA (CDAD) | ||||||||
Patent: | 7,378,508*PED | Patent Expiration: | Jan 31, 2028 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Patent: | 7,863,249*PED | Patent Expiration: | Jan 31, 2028 | Product Flag? | Substance Flag? | Delist Request? | Y |
Complete Access Available with Subscription